Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Results of a large randomized, double-blind study suggest that the TNF inhibitor etanercept (Enbrel; Pfizer) may be more efficacious than sulfasalazine in the…
NEW YORK (Reuters Health) – Intravenous immunoglobulin (IVIG) is not helpful in the treatment of women with unexplained recurrent miscarriage and, for now, should not be used outside…
NEW YORK (Reuters Health) – Basal bolus glargine insulin once daily plus glulisine before meals effectively manages general surgery patients with type 2 diabetes, investigators report. Compared to…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD), an impaired platelet response clopidogrel independently contributes to worse outcomes after percutaneous coronary intervention (PCI), a…
NEW YORK (Reuters Health) – Sumatriptan given subcutaneously relieves cyclic vomiting syndrome associated with migraine, researchers from Japan report in the December 8th online Cephalalgia. “Try sumatriptan for…
NEW YORK (Reuters Health) – It is not advisable to use short-term absorbable sutures for mesh fixation after Lichtenstein inguinal hernioplasty, researchers from Sweden conclude based on review…
NEW YORK (Reuters Health) – The proton pump inhibitor dexlansoprazole modified release (MR) relieves nocturnal heartburn in patients with gastroesophageal reflux disease (GERD), study findings show. As a…
NEW YORK (Reuters Health) – Nephron-sparing surgery is linked to better survival than radical nephrectomy for renal cell carcinoma, even among patients over age 80, study findings show.…
NEW YORK (Reuters Health) – After a first myocardial infarction, treatment with a calcium-channel blocker (CCB) does not appear to diminish the efficacy of clopidogrel, according to results…
NEW YORK (Reuters Health) – The use of artificial colloids for intravascular volume expansion is associated with greater risk of acute kidney injury and impaired coagulation than is…
